Dr. Nova is currently the chief medical officer of Pathway Genomics, and was a founding team member of the company. He is the inventor of the entire nutrition (Pathway FIT/Healthy Weight), Cardiac, and Mental Health line of products for Pathway; and also the Pathway-IBM/Watson Big Data-Deep Learning mobile application: Panorama. Dr Nova has also executed major corporate alliances with companies like Medco/ESI, PepsiCo, DASA (Brazil), Biogenetika (Brazil), Achibadem (Turkey), IHH/Parkway (Singapore), IBM, Florida Hospital Group, Equinox Health, and many others. His scientific career began as a research associate at the Salk Institute in the laboratory of Nobel Laureate Roger Guillemin, where he studied the genetics and proteomics of human growth factors and cancers. Michael was the founder and CEO of Discovery Partners Inc. (Nasdaq: DPII), which completed a successful $150M IPO and marketed wireless drug discovery technology and radiofrequency combinatorial chemistry to large pharmaceutical companies. Intellectual property developed by Dr. Nova at DPII included the original “barcode on bead” patents used by many diagnostic and DNA companies. He then founded the wireless sensory network company Graviton, where he was responsible for raising $60 million in capital from venture groups such as Kleiner Perkins, InQtel and large corporations such as Motorola and Qualcomm. Dr. Nova is also a 2005 World Economic Forum Technology Pioneer Award Winner; and the physician of record on the first person ever to have their entire genome sequenced by Illumina (2009). Dr. Nova has over 30 issued, and 35 pending patents; and he has numerous publications in peer-reviewed journals. With degree’s in biochemistry, physics, and medicine, Dr. Nova is a Board-certified Dermatologist and Dermatopathologist licensed in California. In his minimal spare time, Michael likes to surf big waves in Indonesia and Mexico, and he also helped build a WHO-sanctioned basic care clinic in the Fijian town of Nabila.